Homebiotech

biotech

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026

biotech

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

Jim Cornall - June 25, 2026

biotech

Meteor Biotech joins brain organoids consortium

Jim Cornall - June 25, 2026

biotech

Can food influence gene activity?

Jim Cornall - June 24, 2026

biotech

Lung cancer cells switch identity to resist treatment

Jim Cornall - June 1, 2026

biotech

Could anaemia drug have potential as cancer treatment?

Jim Cornall - June 1, 2026

biotech

Base to Base biotech podcast 61: Making tumours visible, and taking on tough challenges

Jim Cornall - May 29, 2026

biotech

Paediatric pneumococcal vaccine programme advancing

Jim Cornall - May 28, 2026

biotech

FDA clearance for universal dual-target CAR-T candidate

Jim Cornall - May 28, 2026

biotech

Positive data from chronic scrotal content pain trial

Jim Cornall - May 28, 2026

biotech

Thalassaemia treatment gets EU approval

Jim Cornall - May 27, 2026

biotech

New data from Parkinson’s disease trial

Jim Cornall - May 27, 2026

1...567...85 Page 6 of 85

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026 0

Vedana Therapeutics, a biotechnology company developing next-generation therapies for migraine prevention, has emerged from stealth with $46m in Series A financing. The financing was co-led...

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

biotech Jim Cornall - June 25, 2026 0

Meteor Biotech joins brain organoids consortium

biotech Jim Cornall - June 25, 2026 0

Can food influence gene activity?

biotech Jim Cornall - June 24, 2026 0

Lab-engineered proteins: a promising treatment for liver disease

biotech Jim Cornall - June 24, 2026 0